Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Rechon Life Science Employs Scalable Serialization/Aggregation

Sweden pharmaceutical maker and CMO partners adds Adents software on its printing equipment to offer its customers scalable track and trace.

Rechon Life Science AB, a Sweden-based pharmaceuticals developer and contract manufacturer, has partnered with Adents, a provider of serialization and aggregation software, to offer its customers scalable track and trace that complements Rechon’s pharmaceuticals production and packaging services.

In choosing Adents, Rechon addresses compliance with several looming serialization mandates, including the European Union Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act. Eventually, all track and trace applications will interface with Rechon’s Enterprise Resource Planning (ERP) system.

To meet its evolving needs, Rechon required a software solution that was flexible enough to change line configurations per client needs, able to generate and securely import/export unique serial numbers, and offer a workable pricing model. Rechon also sought to use its existing infrastructure to incorporate this serialization plan. Rechon has close ties with ACT-Logimark, a Sweden-based printing equipment provider and systems integration specialist.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?